Kimberly Stone, MD is a board certified General Surgeon who specializes in breast surgical oncology and melanoma surgery. She treats all conditions related to breast health including: breast cancer, high risk prevention and screening, benign breast disease, and conditions related to lactation.
Dr. Stone completed a breast surgical oncology fellowship at UCSF, where she trained in all aspects of breast surgical oncology, and melanoma surgery. Dr Stone performs all types of breast surgery including total skin and nipple sparing mastectomy, wireless lumpectomy, benign breast disease excisions and axillary surgery. She works closely with plastic and reconstructive surgeons to offer women the best possible cosmetic options and results following treatment. Dr Stone performs melanoma surgery including wide local excision, sentinel lymph node biopsy, and lymph node dissections for melanoma.
Dr. Stone strives to deliver compassionate, patient-centered surgical care that is expert and evidence-based while at the same time customized to the unique needs of each patient. She believes that patient empowerment and education are at the heart of an excellent care team.
- Cancer > Breast Cancer
- Breast Surgery
- General Surgery
Clinical Assistant Professor, Surgery - General Surgery
Medical Director, South Bay Operating Room (2018 - Present)
Medical Director, Network Breast Oncology Program (2021 - 2022)
Boards, Advisory Committees, Professional Organizations
Member, American College of Surgeons (2008 - Present)
Member, Alpha Omega Alpha Honors Medical Society (2008 - Present)
Member, Academy of Breastfeeding Medicine (2016 - Present)
Member, American Society or Breast Surgery (2017 - Present)
Residency: Stanford University Dept of General Surgery (2016) CA
Fellowship: Univ of California San Francisco (2018) CA
Fellowship, University of California, San Francisco, Breast Surgical Oncology (2018)
Board Certification, American Board of Surgery, General Surgery (2017)
Residency, Stanford Hospital and Clinics, General Surgery (2016)
Medical Education (MD), University of California, Irvine, Medicine (2009)
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
Lymphedema is a chronic, progressive, and debilitating condition that occurs with disruption or obstruction of the lymphatic system, which commonly occurs a result of breast cancer therapy. The purpose of this study is to determine if the use of a low risk lymphatic reconstruction procedure at the time of axillary lymph node dissection will reduce the risk of developing lymphedema. Additionally, to determine if this procedure improves objective outcomes of lymphedema and patient quality of life
Stanford is currently not accepting patients for this trial. For more information, please contact Dung Nguyen, PharmD, 650-498-6004.
Nipple-areola-complex preservation and obesity-Successful in stages.
The superiority of nipple-sparing mastectomy (NSM) on breast aesthetics and patient-reported outcomes has previously been demonstrated. Despite 42.4% of adults in the United States being considered obese, obesity has been considered a contraindication to NSM due to concerns for nipple areolar complex (NAC) malposition or ischemic complications. This report investigates the feasibility and safety of a staged surgical approach to NSM with immediate microsurgical breast reconstruction in the high-risk obese population.Only patients with a body mass index (BMI) of >30 kg/m2 who underwent bilateral mastopexy or breast reduction for correction of ptosis or macromastia (stage 1), respectively, followed by bilateral prophylactic NSM with immediate microsurgical breast reconstruction with free abdominal flaps (stage 2) were included in the analysis. Patient demographics and surgical outcomes were analyzed.Fifteen patients with high-risk genetic mutations for breast cancer with a mean age and BMI of 41.3 years and 35.0 kg/m2 , respectively, underwent bilateral staged NSM with immediate microsurgical breast reconstruction (30 breast reconstructions). At a mean follow-up of 15.7 months, complications were encountered following stage 2 only and included mastectomy skin necrosis (5 breasts [16.7%]), NAC necrosis (2 breasts [6.7%]), and abdominal seroma (1 patient [6.7%]) all of which were considered minor and neither required surgical intervention nor admission.Implementation of a staged approach permits NAC preservation in obese patients who present for prophylactic mastectomy and immediate microsurgical reconstruction.
View details for DOI 10.1002/micr.31043
View details for PubMedID 37013250
Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery
New England Journal of Medicine Evidence
View details for DOI 10.1056/EVIDoa2200333
Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for Lymphedema Prevention after Axillary Lymph Node Dissection-A Single Institution Experience and Feasibility of Technique.
Journal of clinical medicine
2021; 11 (1)
While surgical options exist to treat lymphedema after axillary lymph node dissection (ALND), the lymphatic microsurgical preventive healing approach (LYMPHA) has been introduced as a preventive measure performed during the primary surgery, thus avoiding the morbidity associated with lymphedema. Here, we highlight details of our operative technique and review postoperative outcomes. For our patients, limb measurements and body composition analyses were performed pre- and postoperatively. Intraoperatively, axillary reverse lymphatic mapping was performed with indocyanine green (ICG) and lymphazurin. SPY-PHI imaging was used to visualize the ICG uptake into axillary lymphatics. Cut lymphatics from excised nodes were preserved for lymphaticovenous anastomosis (LVA). At the completion of the microanastomosis, ICG was visualized draining from the lymphatic through the recipient vein. A retrospective review identified nineteen patients who underwent complete or partial mastectomy with ALND and subsequent LYMPHA over 19 months. The number of LVAs performed per patient ranged between 1-4 per axilla. The operating time ranged from 32-95 min. There were no surgical complications, and thus far one patient developed mild lymphedema with an average follow up of 10 months. At the clinic follow up, ICG and SPY angiography were used to confirm intact lymphatic conduits with an uptake of ICG across the axilla. This study supports LYMPHA as a feasible and effective method for lymphedema prevention.
View details for DOI 10.3390/jcm11010092
View details for PubMedID 35011833
- A randomized phase II study comparing surgical excision versus NeOadjuvant Radiotherapy followed by delayed surgical excision of Ductal carcinoma In Situ (NORDIS) AMER ASSOC CANCER RESEARCH. 2020
The Biology Behind the American College of Surgeons Oncology Group Z0011 Trial
2015; 150 (12): 1148–49
View details for PubMedID 26332793
A Review of Anatomy, Physiology, and Benign Pathology of the Nipple
ANNALS OF SURGICAL ONCOLOGY
2015; 22 (10): 3236-3240
The nipple and areola are pigmented areas of modified skin that connect with the underlying gland of the breast via ducts. The fairly common congenital anomalies of the nipple include inversion, clefts, and supernumerary nipples. The anatomy of the nipple areolar complex is discussed as a foundation to review anatomical variants, and the physiologic development of the nipple, including changes in puberty and pregnancy, as well as the basis of normal physiologic discharge, are addressed. Skin conditions affecting the nipple include eczema, which, while similar to eczema occurring elsewhere on the body, poses unique aspects in terms of diagnosis and treatment. This article concludes with discussion on the benign abnormalities that develop within the nipple, including intraductal papilloma and nipple adenoma.
View details for DOI 10.1245/s10434-015-4760-4
View details for Web of Science ID 000360303800014
View details for PubMedID 26242366